Robert T.S.Latta (Rob)

Partner

San Diego + 1.858.314.1140

Collegati

Condividi

Rob Latta is an intellectual property transactions lawyer focusing on life sciences and environmental sustainability. He advises clients on a range of life science, agrifood, and technology transactions, including licensing, strategic alliances, joint ventures, confidentiality, manufacturing, supply, and distribution agreements. Rob's technical background coupled with extensive experience working within the life sciences allows him to bridge the gap between life sciences and computer sciences industries, particularly in matters related to computational biology and bioinformatics matters.

Rob has extensive experience negotiating complex cross-border collaboration agreements, particularly between the United States and South America, Europe, and Asia, as well as establishing multiparty international drug registries. He also assists clients with evaluating IP in due diligence and negotiates to secure optimal IP positions in connection with the acquisition or divestment of assets in the United States and abroad.

Rob has worked with leading companies in the life sciences and environmental sectors, such as Astellas, Athersys, Biomarin, Celgene, Cibus, Granite Construction, Milliken, NorthStar Group, Organon, Procter & Gamble, and Sanofi.

Rob's technical experience includes small molecule, biologics, gene editing and therapy, medical devices, data management, artificial intelligence, software, and electrical engineering.

Prior to joining Jones Day, Rob was an associate in the San Diego offices of two international law firms where he predominantly worked in patent prosecution and assisted in patent litigation and technology-based transactions. At the start of his career, he practiced intellectual property law in the Columbus, Ohio office of a national law firm.

Esperienze

  • Parker Hannifin sells North America Composites & Fuel Containment Division to SK Capital PartnersJones Day advised Parker Hannifin Corporation in the sale of its North America Composites and Fuel Containment (CFC) Division to private investment firm SK Capital Partners.
  • Materion sells Large Area Targets site to Reliable Silver CorporationJones Day advised Materion Corporation in the sale of its Large Area Targets site in Albuquerque, New Mexico, to Reliable Silver Corporation.
  • TransDigm completes $1.5 billion Senior Secured Notes offering and incurs $1.5 billion of new term loans under its term credit facilityJones Day represented TransDigm Group Incorporated (“TransDigm Group”), a leading global designer, producer and supplier of highly engineered aircraft components, in connection with the Rule 144A and Regulation S offering by TransDigm Inc., its wholly-owned subsidiary, of $1.5 billion aggregate principal amount of 6.000% Senior Secured Notes due 2033 (the “Notes”).
  • Riverside portfolio company acquires Labor Law Center, LLCJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company OutSolve LLC of Labor Law Center, a premier leading provider of labor law compliance services.
  • Closely held private equity firm obtains $31 million term loan credit facility and $10 million trade loan facility for certain portfolio companiesJones Day represented portfolio companies of a private equity firm, including a leading online auction marketplace for the generation and monetization of locally targeted and category-specific consumer demand, and a performance-based marketing solutions company connecting car consumers and dealers, in connection with the refinancing and consolidation of two credit facilities into a $31 million term loan credit facility and a $10 million trade loan credit facility.
  • NOVA Infrastructure sells Bold OceanJones Day advised NOVA Infrastructure in the sale of Bold Ocean, a leading U.S. Flag shipping company serving the critical transportation and logistics needs of numerous U.S. government agencies, to institutional investors advised by J.P. Morgan Global Alternatives' Global Transportation Group.
  • Kowa Pharmaceuticals America signs co-promotion agreement to promote Arcutis's ZORYVE®Jones Day represented Kowa Pharmaceuticals America, Inc. in connection with a co-promotion agreement with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT).
  • Direct lender provides $105 million senior secured credit facility to private equity-backed government software providerJones Day represented a direct lender, as administrative agent and a lender, in connection with a $105 million senior secured credit facility provided to a private equity sponsored company that is a leading provider of transaction and compliance software for state and local governments.
  • ITT completes divestiture of Wolverine Advanced MaterialsJones Day advised ITT, Inc. in the $171 million sale of its Wolverine Advanced Materials business to private equity firm Center Rock Capital Partners.
  • P&G signs exclusive agreement with NewsanJones Day advised The Procter & Gamble Company in the exclusive licensing and distribution agreement with Newsan S.A. for the commercialization in Argentina of P&G’s Gillette, Pantene, Head & Shoulders, Downy, Vick, and Cebión brands (among others), as well as for the manufacturing and commercialization of Pampers diapers and Always pads.
  • Austin Powder sells controlling stake to AIPJones Day is representing Austin Powder, a global leader in blasting services and commercial explosives, in connection with the sale of a controlling stake to American Industrial Partners.
  • STERIS sells dental segment to an affiliate of Peak Rock CapitalJones Day advised STERIS Plc in the $787.5 million sale of Dental segment to Peak Rock Capital, a leading middle-market private investment firm.
  • P&G sells Vidal Sassoon brand in Greater ChinaJones Day advised The Procter & Gamble Company in the sale of its Vidal Sassoon hair care consumer products business to Henkel AG & Co. KGaA.
  • Norwest Equity Partners acquires MDC Interior SolutionsJones Day advised Norwest Equity Partners in the acquisition and financing of MDC Interior Solutions, LLC, a leading commercial interior wallcoverings and design solutions company.
  • TransDigm completes additional $550 million Senior Secured Notes offering and reprices $6.2 billion of existing tranche H and I term loansJones Day represented TransDigm Group Incorporated (“TransDigm Group”), a leading global designer, producer, and supplier of highly engineered aircraft components, in connection with the Rule 144A and Regulation S offering by TransDigm Inc., its wholly-owned subsidiary, of an additional $550 million aggregate principal amount of 6.375% Senior Secured Notes due 2029 (the “Notes”).
  • J.F. Lehman & Company acquires Mission MicrowaveJones Day advised J.F. Lehman & Company in the acquisition and financing of all of the outstanding membership interests of Mission Microwave Technologies, LLC, a revolutionary designer of radio frequency and microwave electronics supporting ground-based, airborne and space-based applications.
  • MPE Partners acquires Webster IndustriesJones Day advised MPE Partners in the acquisition and financing of Webster Industries, Inc., an industrial equipment supplier focused on engineered class chains, sprockets, and vibrating equipment.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Newell Brands amends $1 billion revolving credit facilityJones Day represented Newell Brands Inc. (“Newell”), a leading consumer products company, in connection with the amendment restructuring its existing revolving credit facility.
  • Shiseido Americas acquires Dr. Dennis Gross Skincare for $450 millionJones Day advised Shiseido Americas Corporation, a subsidiary of Shiseido Co., Ltd., in the acquisition of DDG Skincare Holdings LLC, the owner of Dr. Dennis Gross Skincare, for $450 million in cash.
    •

    November 2024 Reprint

    Patent Licensing (The Licensing Journal)

    May 2024 Commentary

    NIH Seeks Comments on Patient Access Plan Requirements in Patent License Agreements

    September 2023 Newsletters

    Vital Signs Digital Health Law Update | Summer 2023

    August 2023 Commentary

    Generative AI End-User License Agreements: What Users Need to Know

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.